5217 related articles for article (PubMed ID: 3280697)
1. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
Aronson PJ; Ito K; Fukaya T; Hashimoto K; Mehregan AH
J Invest Dermatol; 1988 Apr; 90(4):452-8. PubMed ID: 3280697
[TBL] [Abstract][Full Text] [Related]
2. A comparative study on in vitro invasion rates by melanoma cells in the human amniotic basement membrane model versus in vivo tumor nodule formation in C57BL6 mice.
Persky B; Chmielewski GW
Scanning Microsc; 1987 Jun; 1(2):853-62. PubMed ID: 3616579
[TBL] [Abstract][Full Text] [Related]
3. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan.
Di Luzio NR; Williams DL; McNamee RB; Edwards BF; Kitahama A
Int J Cancer; 1979 Dec; 24(6):773-9. PubMed ID: 397198
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic microtubules in two different mouse melanoma cell lines: a qualitative and quantitative analysis using confocal laser scanning microscopy and computer-assisted image analysis.
Fink-Puches R; Hofmann-Wellenhof R; Smolle J; Helige C; Kerl H
J Cutan Pathol; 1997 Jul; 24(6):350-5. PubMed ID: 9243362
[TBL] [Abstract][Full Text] [Related]
5. Pathologic examination of the sentinel lymph node.
Messina JL; Glass LF
J Fla Med Assoc; 1997 Mar; 84(3):153-6. PubMed ID: 9143165
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal melanocyte and keratinocyte melanotropin receptors: visualization by melanotropic peptide conjugated macrospheres (polyamide beads).
Jiang J; Sharma SD; Hruby VJ; Fink JL; Hadley ME
Exp Dermatol; 1997 Feb; 6(1):6-12. PubMed ID: 9067701
[TBL] [Abstract][Full Text] [Related]
7. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
Link EM; Michalowski AS; Rösch F
Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
[TBL] [Abstract][Full Text] [Related]
8. Potential antimelanomic drugs. I. Synthesis and antimelanomic effect of a spin labelled D,L-amino acid containing a 2-chloroethylnitrosocarbamoyl group.
Zheleva A; Raikov Z; Ilarionova M; Carpenter B; Todorov D; Armstrong N
Pharmazie; 1996 Aug; 51(8):602-4. PubMed ID: 8794473
[No Abstract] [Full Text] [Related]
9. Characterization of cultured cells derived from Mongolian gerbil's (Meriones unguiculatus) ascitic malignant melanoma.
Hashimoto O; Miyamoto K; Moritomo T; Saito H; Watanabe T; Mochizuki K
J Vet Med Sci; 1993 Apr; 55(2):227-32. PubMed ID: 8513002
[TBL] [Abstract][Full Text] [Related]
10. Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.
Hom SS; Rosenberg SA; Topalian SL
Cancer Immunol Immunother; 1993; 36(1):1-8. PubMed ID: 8422663
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.
Naramura M; Gillies SD; Mendelsohn J; Reisfeld RA; Mueller BM
Cancer Immunol Immunother; 1993 Oct; 37(5):343-9. PubMed ID: 8402738
[TBL] [Abstract][Full Text] [Related]
12. 5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans.
Olofsson S; Sjöblom I; Hellstrand K; Shugar D; Clairmont C; Hirschberg C
Arch Virol; 1993; 128(3-4):241-56. PubMed ID: 8382038
[TBL] [Abstract][Full Text] [Related]
13. Prothymosin alpha augments deficient antitumor activity of monocytes from melanoma patients in vitro.
Garbin F; Eckert K; Büttner P; Garbe C; Maurer HR
Anticancer Res; 1994; 14(6B):2405-11. PubMed ID: 7872660
[TBL] [Abstract][Full Text] [Related]
14. Ethylene dibromide: evidence of systemic and immunologic toxicity without impairment of in vivo host defenses.
Ratajczak HV; Aranyi C; Bradof JN; Barbera P; Fugmann R; Fenters JD; Thomas PT
In Vivo; 1994; 8(5):879-84. PubMed ID: 7727738
[TBL] [Abstract][Full Text] [Related]
15. [Metastasis of human melanoma in immunodeficient mice. Comparison of lines with varying metastatic activity].
Mikhaĭlov AD; Malakhov AA; Revazova ES; Valiakina TI; Iudicheva TV
Biull Eksp Biol Med; 1995 Feb; 119(2):206-8. PubMed ID: 7670056
[No Abstract] [Full Text] [Related]
16. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
17. Improved tyrosinase activity stains in polyacrylamide electrophoresis gels.
Jimenez-Cervantes C; Valverde P; García-Borrón JC; Solano F; Lozano JA
Pigment Cell Res; 1993 Dec; 6(6):394-9. PubMed ID: 7511805
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural observations on melanosome aggregation in genetically defective melanocytes of the mouse.
Koyama YI; Takeuchi T
Anat Rec; 1981 Dec; 201(4):599-611. PubMed ID: 7340565
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.
Ginsburg E; Gram TE; Trush MA
Cancer Chemother Pharmacol; 1984; 12(2):111-5. PubMed ID: 6199131
[TBL] [Abstract][Full Text] [Related]
20. Degree of differentiation and blood vessel proximity in B16 melanoma.
Paulus G; Hong LX; Atassi G; Buyssens N
Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 39(2):229-38. PubMed ID: 6123193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
